Literature DB >> 24189090

Responsiveness was similar between direct and mapped SF-6D in colorectal cancer patients who declined.

Carlos K H Wong1, Brendan Mulhern2, Yuk-Fai Wan3, Cindy L K Lam3.   

Abstract

OBJECTIVES: To evaluate the responsiveness of generic and mapped preference-based measures based on the anchor of global change in health condition of colorectal cancer (CRC) patients. STUDY DESIGN AND
SETTING: A baseline sample of 333 Chinese CRC patients was recruited between September 2009 and July 2010 and was surveyed prospectively at 6-month follow-up. Preference-based indices were derived from the generic SF-6D measure (SF-6DDirect), from the Short Form-12 (SF-6DSF-12), and mapped from the condition-specific Functional Assessment of Cancer Therapy-Colorectal (SF-6DFACT-C). Responsiveness of three measures was assessed using standardized effect size, standardized response mean, responsiveness statistic, and receiver operating characteristic (ROC) curve analysis.
RESULTS: The SF-6DSF-12 and SF-6DFACT-C indices were significantly more responsive to detect positive changes than the SF-6DDirect index in improved groups. In worsened group, the SF-6DDirect and SF-6DFACT-C indices showed significant decline from baseline to 6-month follow-up. The areas under the ROC curve for SF-6DDirect and SF-6DFACT-C indices were not statistically different from 0.7. The SF-6DFACT-C index was more responsive to changes in health status compared with other indices.
CONCLUSION: Direct SF-6D measure was more responsive than mapped preference-based measures in improved group but the direction was reversed in worsened group. The use of a preference-based index mapped from a condition-specific measure captures both negative and positive important changes among CRC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anchor; Colorectal cancer; Mapping; Preference-based; Responsiveness; SF-6D

Mesh:

Year:  2013        PMID: 24189090     DOI: 10.1016/j.jclinepi.2013.08.011

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  10 in total

1.  The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers: a comparison of regression-based methods.

Authors:  Nick Kontodimopoulos
Journal:  Qual Life Res       Date:  2014-11-13       Impact factor: 4.147

2.  Improving the mapping of condition-specific health-related quality of life onto SF-6D score.

Authors:  Yingsi Yang; M Y Wong; Cindy L K Lam; Carlos K H Wong
Journal:  Qual Life Res       Date:  2014-03-29       Impact factor: 4.147

3.  The internal and external responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in patients with prostate cancer.

Authors:  Edmond P H Choi; Carlos K H Wong; Eric Y F Wan; James H L Tsu; W Y Chin; Kenny Kung; M K Yiu
Journal:  Qual Life Res       Date:  2016-02-23       Impact factor: 4.147

4.  EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.

Authors:  Mihir Gandhi; Marcus Ang; Kelvin Teo; Chee Wai Wong; Yvonne Chung-Hsi Wei; Rachel Lee-Yin Tan; Mathieu F Janssen; Nan Luo
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

5.  Evaluation of patient-reported outcomes data in structured diabetes education intervention: 2-year follow-up data of patient empowerment programme.

Authors:  Carlos K H Wong; Cindy L K Lam; Eric Y F Wan; Anca K C Chan; C H Pak; Frank W K Chan; William C W Wong
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

6.  Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.

Authors:  Carlos K H Wong; Cindy L K Lam; Y F Wan; Daniel Y T Fong
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

7.  Having a Family Doctor is Associated with Some Better Patient-Reported Outcomes of Primary Care Consultations.

Authors:  Cindy L K Lam; Esther Y T Yu; Yvonne Y C Lo; Carlos K H Wong; Stewart M Mercer; Daniel Y T Fong; Albert Lee; Tai Pong Lam; Gabriel M Leung
Journal:  Front Med (Lausanne)       Date:  2014-09-15

Review 8.  Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review.

Authors:  Xinyu Qian; Rachel Lee-Yin Tan; Ling-Hsiang Chuang; Nan Luo
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

9.  Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.

Authors:  Carlos K H Wong; Wai-Lun Law; Yuk-Fai Wan; Jensen Tung-Chung Poon; Cindy Lo-Kuen Lam
Journal:  BMC Cancer       Date:  2014-05-17       Impact factor: 4.430

Review 10.  Systematic review of health state utility values for economic evaluation of colorectal cancer.

Authors:  Kim Jeong; John Cairns
Journal:  Health Econ Rev       Date:  2016-08-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.